Kathelijne Peerlinck is a scholar working on Hematology, Genetics and Surgery.
According to data from OpenAlex, Kathelijne Peerlinck has authored 133 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Hematology, 23 papers in Genetics and 16 papers in Surgery. Recurrent topics in Kathelijne Peerlinck's work include Hemophilia Treatment and Research (73 papers), Platelet Disorders and Treatments (53 papers) and Blood Coagulation and Thrombosis Mechanisms (38 papers). Kathelijne Peerlinck is often cited by papers focused on Hemophilia Treatment and Research (73 papers), Platelet Disorders and Treatments (53 papers) and Blood Coagulation and Thrombosis Mechanisms (38 papers). Kathelijne Peerlinck collaborates with scholars based in Belgium, United States and Netherlands. Kathelijne Peerlinck's co-authors include Jos Vermylen, Marc Jacquemin, Jef Arnout, Jean‐Marie Saint‐Remy, Renaud Lavend’homme, Marc Hoylaerts, Jean Guy Gilles, Hans Deckmyn, J. Vermylen and Katrien Devreese and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.
In The Last Decade
Kathelijne Peerlinck
129 papers
receiving
3.4k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
2019273 citationsKathelijne Peerlinck et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Kathelijne Peerlinck
Since
Specialization
Citations
This map shows the geographic impact of Kathelijne Peerlinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathelijne Peerlinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathelijne Peerlinck more than expected).
Fields of papers citing papers by Kathelijne Peerlinck
This network shows the impact of papers produced by Kathelijne Peerlinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathelijne Peerlinck. The network helps show where Kathelijne Peerlinck may publish in the future.
Co-authorship network of co-authors of Kathelijne Peerlinck
This figure shows the co-authorship network connecting the top 25 collaborators of Kathelijne Peerlinck.
A scholar is included among the top collaborators of Kathelijne Peerlinck based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Kathelijne Peerlinck. Kathelijne Peerlinck is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lobet, Sébastien, Cédric Hermans, Kathelijne Peerlinck, et al.. (2015). Deficit of Functional Ankle Muscle Strength is Not Found in Young Haemophiliacs With Confirmed Structural Impairment. Haemophilia. 21(6).1 indexed citations
Velzen, Alice S. van, Matthew Peters, Marieke J. H. A. Kruip, et al.. (2015). DDAVP in moderate hemophilia a patients: a treatment strategy worth considering. Journal of Thrombosis and Haemostasis. 13. 97–98.1 indexed citations
10.
Jacquemin, Marc, et al.. (2015). The type of reagents determines the accuracy of calibration with a product specific standard for the measurement of the B-domain deleted RFVIII Moroctocog alfa-AF activity. Journal of Thrombosis and Haemostasis. 13. 560–560.1 indexed citations
11.
Powell, Jerry S., Shashikant Apte, Hérvè Chambost, et al.. (2013). Long-lasting recombinant factor FIX Fc fusion (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study. Journal of Thrombosis and Haemostasis. 11. 358–358.4 indexed citations
12.
Jacquemin, Marc, Renaud Lavend’homme, Jean-Marie Saint-Remy, & Kathelijne Peerlinck. (2007). Activation of human endothelial cells induces the release of a FVIII storage pool. Journal of Thrombosis and Haemostasis. 5.1 indexed citations
Goossens, Godelieve, et al.. (2005). Occlusion in totally implantable vascular access devices: what is its incidence and what actions do nurses take to restore patency?. European Journal of Cancer Supplements. 3(2). 460.1 indexed citations
15.
d’Oiron, Roseline, J. M. Lavergne, J Peynet, et al.. (2003). Response to DDAVP in mild/moderate haemophilia A patients according to the underlying Factor VIII genotype. Journal of Thrombosis and Haemostasis. 1.4 indexed citations
Peerlinck, Kathelijne, Jozef Arnout, Marc Jacquemin, et al.. (1997). A patient with mild hemophilia A and a high titer antifactor VIII antibody against exogenous factor VIII only: clinical features, surgical management, and partial characterization of the inhibitor. Blood. 90.3 indexed citations
18.
Tornai, István, et al.. (1991). A murine monoclonal-antibody against vonwillebrand-factor (vwf) increases vwf binding to human platelet glycoprotein (gp) ib and gp iib/iiia. Thrombosis and Haemostasis. 65(6). 973–973.2 indexed citations
19.
Peerlinck, Kathelijne, et al.. (1991). An easy method to detect patients with vonwillebrand-factor defective in fviii-binding. Thrombosis and Haemostasis. 65(6). 972–972.1 indexed citations
20.
Tornai, István, Paul Declerck, Jozef Arnout, et al.. (1991). Measurement of vonwillebrand-factor antigen in plasma and platelets with an enzyme-linked-immunosorbent-assay based on 2 murine monoclonal-antibodies. Thrombosis and Haemostasis. 65(6). 1128–1128.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.